Haemoglobin-based oxygen carriers

Expert Opinion on Investigational Drugs

Volumn 9, Issue 9, 2000, Pages 1967-1984

  Vandegriff, K D ^a  

^a SANGART INC   (United States)

Author keywords

Blood replacement therapy; Blood substitutes; Haemoglobin; Oxygen carriers; Surgical blood loss; Trauma

Indexed keywords

CARRIER PROTEIN; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; HEMOSPAN; MACROGOL; OXYGEN; POLYMERIZED HEMOGLOBIN; PYRIDOXYLHEMOGLOBIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD FLOW; BLOOD TRANSFUSION; BRADYCARDIA; CELL FREE SYSTEM; CIRCULATION; CLINICAL TRIAL; CONJUGATION; CROSS LINKING; DRUG INDICATION; ELECTIVE SURGERY; GASTROINTESTINAL DISEASE; GENETIC ENGINEERING; HEART OUTPUT; HEMODILUTION; HEMODYNAMICS; HUMAN; IMMUNOTOXICITY; INJURY; MEAN ARTERIAL PRESSURE; NEUROTOXICITY; PERIOPERATIVE PERIOD; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POLYMERIZATION; RESUSCITATION; REVIEW; SIDE EFFECT; TECHNOLOGY; VASCULAR RESISTANCE;

EID: 0033856049     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.9.1967     Document Type: Review

References (71)

1. New transfusion strategies: Red cell substitutes
2. Stabilized hemoglobin vesicles
3. Encapsulation of hemoglobin in liposomes
4. Blood substitutes
5. Hemoglobin-based Red Cell Substitutes
6. 0 for possible use as a blood substitute
7. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties
8. Expression of fully functional tetrameric human hemoglobin in Escherichia coli
9. Synthesis of wild type and mutant human hemoglobins in Saccharomyces cerevisiae
10. Clinical experience with hemoglobin-saline solutions
11. Evaluation of stroma-free haemoglobin for use as a plasma expander
12. The renal handling of hemoglobin
13. A clinical safety trial of stroma-free hemoglobin
14. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin
15. Microcirculatory consequences of blood substitution with αα-hemoglobin
16. Safety of the blood supply in the United States: Opportunities and controversies
17. Creutzfeldt-Jacob disease latest unknown in struggle to restore faith in blood supply
18. Decrease in frequency of transfusion fatalities
19. Blood transfusion
20. Collection and transfusion of blood and blood components in the United States, 1994
21. Epidemiology of red blood cell utilization
22. Erythropoietin response to blood substitutes: A model for tissue hypoxia
23. 2)
24. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock
25. Baxter to focus on next-generation oxygen-carrying therapeutics; decision will end clinical development of first-generation programs
26. A human recombinant haemoglobin
27. Polymerized pyridoxylated hemoglobin: A red cell substitute with normal oxygen capacity
28. Ultrapure, stroma-free, polymerized bovine hemoglobin solution: Evaluation of renal toxicity
29. Demonstration of the efficacy of a therapeutic agent
30. Phase I study of the safety and pharmacologic effects of diaspirin crosslinked hemoglobin solution
31. The pressor effect of hemoglobin - Good or bad?
32. The hemodynamic effects of diaspirin cross-linked hemoglobin (DCLHb) in the operative setting
33. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients
34. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke
35. Clinical benefits of DCLHb following cardiac surgery
36. Outcome after hemorrhagic shock in trauma patients
37. Emergency medicine and the development of the Food and Drug Administration's final rule on informed consent in emergency research circumstances
38. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
39. Current issues in blood substitutes
40. The effects of recombinant human hemoglobin on esophageal motor function in humans
41. Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery
42. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery
43. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans
44. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery
45. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects
46. A Phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study
47. Hemolink-induced effects on intestinal motor function and attenuation of these effects by selected agents
48. Blood substitutes
49. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model
50. Cardiovascular and hemorheological effects of dextran-conjugated hemoglobin, αα-crosslinked hemoglobin and o-raffinose polymerized hemoglobin in hemodiluted rabbits
51. 2 carriers determine constriction of resistance arteries and hypertension
52. Use of base deficit to compare resuscitation with lactated Ringer's solution, Haemaccel, whole blood and diaspirin cross-linked hemoglobin following hemorrhage in rats
53. Diaspirin cross-linked hemoglobin resuscitation of hemorrhage
54. The efficacy of diaspirin crosslinked hemoglobin solution resuscitation in a model of uncontrolled hemorrhage
55. αα-Crosslinked hemoglobin: Was failure predicted by preclinical testing?
56. Resuscitation and the limited utility of the present generation of blood substitutes
57. EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries
58. Flow effects on prostacyclin production in cultured human endothelial cells
59. Oxygen gradients between red blood cells in the microcirculation
60. A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries
61. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance
62. Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle
63. A theoretical analysis of oxygen transport: A new strategy for the design of hemoglobin-based red cell substitutes
64. Hemoglobin oxygen affinity and the design of red cell substitutes
65. Nitric oxide binding and the adverse effects of cell-free hemoglobins: What makes us different from earthworms
66. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide
67. Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the rat mesentery
68. Points to consider in the safety and evaluation of hemoglobin-based oxygen carriers
69. Points to consider on efficacy evaluation of hemoglobin- and perfluorocarbon-based oxygen carriers
70. Pivotal clinical trials of blood substitutes begin
71. Stover and Associates L: A new generation of oxygen therapeutics